Literature DB >> 15660415

Abnormal cell cycle regulation in primary human uveal melanoma cultures.

María Pardo1, Antonio Piñeiro, María de la Fuente, Angel García, Sripadi Prabhakar, Nicole Zitzmann, Raymond A Dwek, Manuel Sánchez-Salorio, Fernando Domínguez, Carmen Capeans.   

Abstract

Uveal malignant melanoma is the most frequent primary intraocular tumor in adult humans. The cellular events leading to neoplasic transformation of normal uveal melanocytes are not well known when compared to other cancers. In this study, we investigated the role of G1 and G1/S regulatory proteins of the cell cycle in human uveal melanoma (UM) primary cell cultures, since these proteins are common targets in tumor development. Further, freshly established and characterized tumor cells are a better model for in vitro studies when compared to cell lines established long ago. Human primary cell cultures from eight different UM were established, as well as one primary culture from rhesus uveal normal melanocytes (UNM). Primary human UM cultures were characterized by a low establishment and growing rate. From four successful cultures, three showed a high expression of cyclin D1, cyclin E, p16NK4A, and p27KIP1 with no variations in cyclin A, cyclin-dependent kinase 2 (CDK2), and CDK4. Interestingly, in one of the cultured tumors, tumor suppressor protein retinoblastoma (Rb) did not bind E2F despite the fact that Rb was found in its hypophosphorylated form. No mutations in either RB1 or the Rb-binding pocket of E2F-1 were detected. Furthermore, we identified seven proteins co-immunoprecipitating with Rb in this tumor, including Lamin A/C and six proteins not previously reported to bind Rb: Hsc70, high mobility group protein 1 (HMG-1), hnRPN, glyceraldehyde 3 phosphate dehydrogenase (G3PDH), EF-1, and EF-2. Our results indicate that the overexpression of cyclins D1/E and CDKIs p16 and p27, together with a deregulation of the Rb/E2F pathway, may be implicated in the development of human UM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15660415     DOI: 10.1002/jcb.20230

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.

Authors:  Bruno Augusto Benevenuto de Andrade; Jorge Esquiche León; Román Carlos; Wilson Delgado-Azañero; Adalberto Mosqueda-Taylor; Oslei Paes de Almeida
Journal:  Head Neck Pathol       Date:  2012-02-05

Review 2.  Culturing Uveal Melanoma Cells.

Authors:  Martina Angi; Mieke Versluis; Helen Kalirai
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

3.  A comparative transcriptomic analysis of uveal melanoma and normal uveal melanocyte.

Authors:  Jianhong An; Haolei Wan; Xiangtian Zhou; Dan-Ning Hu; Ledan Wang; Lili Hao; Dongsheng Yan; Fanjun Shi; Zhonglou Zhou; Jiao Wang; Songnian Hu; Jun Yu; Jia Qu
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 4.  Proteomics in uveal melanoma.

Authors:  Michael J Heiferman; Vinit B Mahajan; Prithvi Mruthyunjaya
Journal:  Curr Opin Ophthalmol       Date:  2022-01-31       Impact factor: 4.299

5.  SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma.

Authors:  Fengxi Meng; Yiqun Yuan; Hui Ren; Han Yue; Binbin Xu; Jiang Qian
Journal:  Cancer Sci       Date:  2021-12-20       Impact factor: 6.716

Review 6.  Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.

Authors:  Binapani Mahaling; Shermaine W Y Low; Molly Beck; Devesh Kumar; Simrah Ahmed; Thomas B Connor; Baseer Ahmad; Shyam S Chaurasia
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

7.  ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.

Authors:  G De la Houssaye; V Vieira; C Masson; F Beermann; J L Dufier; M Menasche; M Abitbol
Journal:  Mol Vis       Date:  2008-10-29       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.